These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 32212912)

  • 21. Cardio-ankle vascular index is linked to deranged metabolic status, especially high HbA1c and monocyte-chemoattractant-1 protein, in predialysis chronic kidney disease.
    Mert M; Dursun B; Yağcı AB; Çetin Kardeşler A; Şenol H; Demir S
    Int Urol Nephrol; 2020 Jan; 52(1):137-145. PubMed ID: 31773386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential application of klotho in human chronic kidney disease.
    Neyra JA; Hu MC
    Bone; 2017 Jul; 100():41-49. PubMed ID: 28115282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle.
    de Albuquerque Suassuna PG; Sanders-Pinheiro H; de Paula RB
    Front Med (Lausanne); 2018; 5():206. PubMed ID: 30087898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extrarenal effects of FGF23.
    Haffner D; Leifheit-Nestler M
    Pediatr Nephrol; 2017 May; 32(5):753-765. PubMed ID: 27704252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
    Yanucil C; Kentrup D; Campos I; Czaya B; Heitman K; Westbrook D; Osis G; Grabner A; Wende AR; Vallejo J; Wacker MJ; Navarro-Garcia JA; Ruiz-Hurtado G; Zhang F; Song Y; Linhardt RJ; White K; Kapiloff MS; Faul C
    Kidney Int; 2022 Aug; 102(2):261-279. PubMed ID: 35513125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.
    Hu MC; Shiizaki K; Kuro-o M; Moe OW
    Annu Rev Physiol; 2013; 75():503-33. PubMed ID: 23398153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF23 regulates renal sodium handling and blood pressure.
    Andrukhova O; Slavic S; Smorodchenko A; Zeitz U; Shalhoub V; Lanske B; Pohl EE; Erben RG
    EMBO Mol Med; 2014 Jun; 6(6):744-59. PubMed ID: 24797667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
    Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
    Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Klotho and chronic kidney disease.
    Hu MC; Kuro-o M; Moe OW
    Contrib Nephrol; 2013; 180():47-63. PubMed ID: 23652549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.
    Wang X; Liu J; Drummond CA; Shapiro JI
    Expert Opin Ther Targets; 2017 May; 21(5):531-541. PubMed ID: 28338377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy.
    Patel RK; Mark PB; Halliday C; Steedman T; Dargie HJ; Cobbe SM; Jardine AG
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):519-27. PubMed ID: 21088291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injury.
    Epstein M; Freundlich M
    Nephrol Dial Transplant; 2022 Jan; 37(2):211-221. PubMed ID: 34459924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease.
    Eisenga MF; Emans ME; van der Putten K; Cramer MJ; Diepenbroek A; Velthuis BK; Doevendans PA; Verhaar MC; Joles JA; Bakker SJL; Nolte IM; Braam B; Gaillard CAJM
    J Am Heart Assoc; 2019 Aug; 8(16):e011130. PubMed ID: 31423921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
    Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
    Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia.
    Lin CY; Hsu YJ; Hsu SC; Chen Y; Lee HS; Lin SH; Huang SM; Tsai CS; Shih CC
    J Mol Cell Cardiol; 2015 Aug; 85():249-61. PubMed ID: 26093151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].
    Milovanova LY; Kozlovskaya LV; Markina MM; Milovanova SY; Borisov AA; Mukhin NA; Fomin VV; Moiseev SV
    Klin Med (Mosk); 2015; 93(12):32-8. PubMed ID: 27149811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.